Fri 15'th Jun 2018
ImmunoCellular Therapeutics Ltd Stock Analysis
Technical stock analysis for Fri 15'th Jun 2018
ImmunoCellular Therapeutics Ltd gained 5.92% in the last trading day, rising from $0.25 to $0.27 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 8% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 24 874 more shares were traded than the day before. In total, 261 632 shares bought and sold for approximately $0.00.
|Shorts||5.48% ( 2018-05-31 )|
ImmunoCellular Therapeutics Ltd lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.21% during the next 3 months and, with 90% probability hold a price between $0.24 and $0.30 at the end of this period.
Only positive signals in the chart today. ImmunoCellular Therapeutics Ltd holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $0.26 and $0.26. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday June 13, 2018, which indicates further gains until a new top pivot has been found. ImmunoCellular Therapeutics Ltd has rising volume and follows the last lift in the price. This considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 48 and the stock is currently not being overbought or oversold
Support & Resistance
ImmunoCellular Therapeutics Ltd finds support from accumulated volume at $0.27.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 8.00%. For the last week, the stock has had a daily average volatility of 6.14%.
Our recommended stoploss: $0.26 (-4.55%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)
Very Low Low Medium High Very High
Trade IMUC CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder